Andrew Booth Ab Cellera Biologics Inc. (ABCL) insider trading activity

Andrew Booth is Chief Financial Officer of AbCellera Biologics Inc.. Currently has a direct ownership of 153,000 shares of ABCL, which is worth approximately $417,690. The most recent transaction as insider was on May 26, 2023, when has been sold 14,500 shares (Common Shares) at a price of $6.85 per share, resulting in proceeds of $99,325. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 153K

0% 3M change

0% 12M change

Total Value Held $417,690

Andrew Booth Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 26 2023	BUY Open market or private purchase	$99,325 $6.85 p/Share	14,500 Added 8.66%	153,000 Common Shares
Dec 20 2022	SELL Bona fide gift	-	50,000 Reduced 26.53%	138,500 Common Shares
Dec 20 2022	BUY Exercise of conversion of derivative security	$9,500 $0.19 p/Share	50,000 Added 20.96%	188,500 Common Shares
May 12 2022	BUY Open market or private purchase	$492,150 $5.79 p/Share	85,000 Added 38.03%	138,500 Common Shares
Dec 10 2021	BUY Exercise of conversion of derivative security	$160,000 $0.32 p/Share	500,000 Added 47.46%	553,500 Common Shares
Nov 11 2021	BUY Open market or private purchase	$788,590 $14.74 p/Share	53,500 Added 50.0%	53,500 Common Shares
Jun 09 2021	SELL Open market or private sale	$30,600,000 $25.5 p/Share	1,200,000 Reduced 100.0%	0 Common Shares
Jun 07 2021	BUY Exercise of conversion of derivative security	$312,000 $0.26 p/Share	1,200,000 Added 50.0%	1,200,000 Common Shares

Andrew Booth

Chief Financial Officer

Vancouver, A1

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABCL shares.

Notify only if

Value

Insider Trading

Get notified when an Ab Cellera Biologics Inc. insider buys or sells ABCL shares.

Notify only if

Operation

Value

Type

News

Receive news related to AbCellera Biologics Inc.

Track Activities on ABCL

Account